Tapewire

Nasdaq · USD

MPLT

MapLight Therapeutics, Inc.

Export transactions ↓
Tapewire entity
5316
SEC CIK
0001770069
Parsed reports
94

Last 12 months

Inside the activity.

10 purchase rows · 139 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202604
Feb 202649
Mar 202600
Apr 2026026
May 2026054
Jun 202600
Jul 2026544
Aug 202611
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 28, 2025 Filed Oct 28, 2025 20:15 UTC
Kroeger Christopher A.Director · Chief Executive Officer
ConversionVoting Common Stock 3,895 Not disclosed Not disclosed
Disclosure

SEC source: 0001658918-25-000008 · form4-10282025_041001.xml · nonDerivative · entry 2

Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 229,588

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: The Series C Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's IPO for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

Read SEC document
October 28, 2025 Filed Oct 29, 2025 20:16 UTC ConversionSeries D Preferred Stock · Derivative 6,678,910 Not disclosed Not disclosed
Disclosure

SEC source: 0001900201-25-000008 · form4-10292025_081047.xml · derivative · entry 8

Catalyst4, Inc. · CIK 0001900201 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Voting Common Stock · 6,678,910 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: The Series D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

F8 · price: The Series D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

F8 · derivative.exercise_date: The Series D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

F8 · derivative.expiration_date: The Series D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

F2 · ownership.nature: The shares are held of record by Catalyst4, Inc. ("Catalyst4"). As the members of the board of directors of Catalyst4, Robert Brown, Ekemini Riley and Mark Vorsatz share voting and dispositive power with respect to the shares held by Catalyst4. Each of Mr. Brown, Ms. Riley and Mr. Vorsatz disclaims beneficial ownership of the shares reported herein.

Read SEC document
October 28, 2025 Filed Oct 29, 2025 20:16 UTC ConversionSeries C Preferred Stock · Derivative 5,444,807 Not disclosed Not disclosed
Disclosure

SEC source: 0001900201-25-000008 · form4-10292025_081047.xml · derivative · entry 7

Catalyst4, Inc. · CIK 0001900201 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Voting Common Stock · 5,444,807 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: The Series C Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

F7 · price: The Series C Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

F7 · derivative.exercise_date: The Series C Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

F7 · derivative.expiration_date: The Series C Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

F2 · ownership.nature: The shares are held of record by Catalyst4, Inc. ("Catalyst4"). As the members of the board of directors of Catalyst4, Robert Brown, Ekemini Riley and Mark Vorsatz share voting and dispositive power with respect to the shares held by Catalyst4. Each of Mr. Brown, Ms. Riley and Mr. Vorsatz disclaims beneficial ownership of the shares reported herein.

Read SEC document
October 28, 2025 Filed Oct 29, 2025 20:16 UTC ConversionSeries B-1 Preferred Stock · Derivative 275,148 Not disclosed Not disclosed
Disclosure

SEC source: 0001900201-25-000008 · form4-10292025_081047.xml · derivative · entry 6

Catalyst4, Inc. · CIK 0001900201 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Voting Common Stock · 275,148 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: The Series B-1 Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

F6 · price: The Series B-1 Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

F6 · derivative.exercise_date: The Series B-1 Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

F6 · derivative.expiration_date: The Series B-1 Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

F2 · ownership.nature: The shares are held of record by Catalyst4, Inc. ("Catalyst4"). As the members of the board of directors of Catalyst4, Robert Brown, Ekemini Riley and Mark Vorsatz share voting and dispositive power with respect to the shares held by Catalyst4. Each of Mr. Brown, Ms. Riley and Mr. Vorsatz disclaims beneficial ownership of the shares reported herein.

Read SEC document
October 28, 2025 Filed Oct 29, 2025 20:16 UTC ConversionSeries B Preferred Stock · Derivative 1,263,768 Not disclosed Not disclosed
Disclosure

SEC source: 0001900201-25-000008 · form4-10292025_081047.xml · derivative · entry 5

Catalyst4, Inc. · CIK 0001900201 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Voting Common Stock · 1,263,768 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The Series B Preferred Stock is convertible on a 1-for-16.8 basis into voting common stock at any time at the holder's election and will convert automatically upon the closing of the Issuer's initial public offering and has no expiration date.

F5 · price: The Series B Preferred Stock is convertible on a 1-for-16.8 basis into voting common stock at any time at the holder's election and will convert automatically upon the closing of the Issuer's initial public offering and has no expiration date.

F5 · derivative.exercise_date: The Series B Preferred Stock is convertible on a 1-for-16.8 basis into voting common stock at any time at the holder's election and will convert automatically upon the closing of the Issuer's initial public offering and has no expiration date.

F5 · derivative.expiration_date: The Series B Preferred Stock is convertible on a 1-for-16.8 basis into voting common stock at any time at the holder's election and will convert automatically upon the closing of the Issuer's initial public offering and has no expiration date.

F2 · ownership.nature: The shares are held of record by Catalyst4, Inc. ("Catalyst4"). As the members of the board of directors of Catalyst4, Robert Brown, Ekemini Riley and Mark Vorsatz share voting and dispositive power with respect to the shares held by Catalyst4. Each of Mr. Brown, Ms. Riley and Mr. Vorsatz disclaims beneficial ownership of the shares reported herein.

Read SEC document
October 28, 2025 Filed Oct 29, 2025 20:16 UTC ConversionSeries A-1 Preferred Stock · Derivative 444,846 Not disclosed Not disclosed
Disclosure

SEC source: 0001900201-25-000008 · form4-10292025_081047.xml · derivative · entry 4

Catalyst4, Inc. · CIK 0001900201 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Voting Common Stock · 444,846 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The Series A-1 Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

F4 · price: The Series A-1 Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

F4 · derivative.exercise_date: The Series A-1 Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

F4 · derivative.expiration_date: The Series A-1 Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

F2 · ownership.nature: The shares are held of record by Catalyst4, Inc. ("Catalyst4"). As the members of the board of directors of Catalyst4, Robert Brown, Ekemini Riley and Mark Vorsatz share voting and dispositive power with respect to the shares held by Catalyst4. Each of Mr. Brown, Ms. Riley and Mr. Vorsatz disclaims beneficial ownership of the shares reported herein.

Read SEC document
October 28, 2025 Filed Oct 29, 2025 20:16 UTC ConversionSeries A Preferred Stock · Derivative 148,809 Not disclosed Not disclosed
Disclosure

SEC source: 0001900201-25-000008 · form4-10292025_081047.xml · derivative · entry 3

Catalyst4, Inc. · CIK 0001900201 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Voting Common Stock · 148,809 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Series A Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

F3 · price: The Series A Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

F3 · derivative.exercise_date: The Series A Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

F3 · derivative.expiration_date: The Series A Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

F2 · ownership.nature: The shares are held of record by Catalyst4, Inc. ("Catalyst4"). As the members of the board of directors of Catalyst4, Robert Brown, Ekemini Riley and Mark Vorsatz share voting and dispositive power with respect to the shares held by Catalyst4. Each of Mr. Brown, Ms. Riley and Mr. Vorsatz disclaims beneficial ownership of the shares reported herein.

Read SEC document
October 28, 2025 Filed Oct 29, 2025 20:16 UTC PurchaseVoting Common Stock 5,441,176 $17.00 $92,499,992.00
Disclosure

SEC source: 0001900201-25-000008 · form4-10292025_081047.xml · nonDerivative · entry 2

Catalyst4, Inc. · CIK 0001900201 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 19,697,464

F2 · ownership.nature: The shares are held of record by Catalyst4, Inc. ("Catalyst4"). As the members of the board of directors of Catalyst4, Robert Brown, Ekemini Riley and Mark Vorsatz share voting and dispositive power with respect to the shares held by Catalyst4. Each of Mr. Brown, Ms. Riley and Mr. Vorsatz disclaims beneficial ownership of the shares reported herein.

Read SEC document
October 28, 2025 Filed Oct 29, 2025 20:16 UTC ConversionVoting Common Stock 14,256,288 Not disclosed Not disclosed
Disclosure

SEC source: 0001900201-25-000008 · form4-10292025_081047.xml · nonDerivative · entry 1

Catalyst4, Inc. · CIK 0001900201 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 14,256,288

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Series A, A-1, B, B-1, C and D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

F2 · ownership.nature: The shares are held of record by Catalyst4, Inc. ("Catalyst4"). As the members of the board of directors of Catalyst4, Robert Brown, Ekemini Riley and Mark Vorsatz share voting and dispositive power with respect to the shares held by Catalyst4. Each of Mr. Brown, Ms. Riley and Mr. Vorsatz disclaims beneficial ownership of the shares reported herein.

Read SEC document
October 28, 2025 Filed Oct 30, 2025 20:31 UTC ConversionSeries D Preferred Stock · Derivative 19,734,671 $0.00 $0.00
Disclosure

SEC source: 0001388325-25-000018 · form4-10302025_081039.xml · derivative · entry 4

Novo Holdings A/S · CIK 0001388325 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Voting Common Stock · 1,174,682 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Series C Preferred Stock and Series D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

F1 · derivative.exercise_date: The Series C Preferred Stock and Series D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

F1 · derivative.expiration_date: The Series C Preferred Stock and Series D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

Read SEC document
October 28, 2025 Filed Oct 30, 2025 20:31 UTC ConversionSeries C Preferred Stock · Derivative 26,191,207 $0.00 $0.00
Disclosure

SEC source: 0001388325-25-000018 · form4-10302025_081039.xml · derivative · entry 3

Novo Holdings A/S · CIK 0001388325 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Voting Common Stock · 1,558,999 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Series C Preferred Stock and Series D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

F1 · derivative.exercise_date: The Series C Preferred Stock and Series D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

F1 · derivative.expiration_date: The Series C Preferred Stock and Series D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

Read SEC document
October 28, 2025 Filed Oct 30, 2025 20:31 UTC PurchaseVoting Common Stock 952,941 $17.00 $16,199,997.00
Disclosure

SEC source: 0001388325-25-000018 · form4-10302025_081039.xml · nonDerivative · entry 2

Novo Holdings A/S · CIK 0001388325 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,686,622

F2 · shares: Represents a purchase from the underwriters in the Issuer's initial public offering.

Read SEC document
October 28, 2025 Filed Oct 30, 2025 20:31 UTC ConversionVoting Common Stock 2,733,681 Not disclosed Not disclosed
Disclosure

SEC source: 0001388325-25-000018 · form4-10302025_081039.xml · nonDerivative · entry 1

Novo Holdings A/S · CIK 0001388325 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,733,681

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Series C Preferred Stock and Series D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

Read SEC document
October 27, 2025 Filed Oct 28, 2025 20:15 UTC GrantEmployee Stock Option (right to buy) · Derivative 25,604 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0001998937-25-000006 · form4-10282025_041020.xml · derivative · entry 2

Garnett Timothy John · CIK 0001998937 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,604

Underlying: Voting Common Stock · 25,604 shares

Expires 2035-10-26

F3 · derivative.exercise_date: 1/4th of the total shares underlying the option shall vest on October 1, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.

Read SEC document
October 27, 2025 Filed Oct 28, 2025 20:15 UTC GrantVoting Common Stock 6,294 $0.00 $0.00
Disclosure

SEC source: 0001998937-25-000006 · form4-10282025_041020.xml · nonDerivative · entry 1

Garnett Timothy John · CIK 0001998937 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,294

F1 · shares: Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on October 1, 2026, and 1/16th of the RSUs shall vest on each subsequent January 1, April 1, July 1 and October 1 thereafter, subject to the Reporting Person's continued service through each vesting date.

F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.

Read SEC document
October 27, 2025 Filed Oct 28, 2025 20:15 UTC GrantEmployee Stock Option (right to buy) · Derivative 139,610 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0002021198-25-000006 · form4-10282025_041005.xml · derivative · entry 3

Malenka Robert C. · CIK 0002021198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,610

Underlying: Voting Common Stock · 139,610 shares

Expires 2035-10-26

F5 · derivative.exercise_date: 1/4th of the total shares underlying the option shall vest on October 1, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.

Read SEC document
October 27, 2025 Filed Oct 28, 2025 20:15 UTC GrantVoting Common Stock 34,390 $0.00 $0.00
Disclosure

SEC source: 0002021198-25-000006 · form4-10282025_041005.xml · nonDerivative · entry 1

Malenka Robert C. · CIK 0002021198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 399,671

F1 · shares: Represents a restricted stock unit ("RSU") award. 25% of the RSUs shall vest on October 1, 2026, and 1/16th of the RSUs shall vest on each subsequent January 1, April 1, July 1 and October 1 thereafter, subject to the Reporting Person's continued service through each vesting date.

F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.

Read SEC document
October 27, 2025 Filed Oct 28, 2025 20:15 UTC
Kreitzer AnatolChief Discovery Officer
GrantEmployee Stock Option (right to buy) · Derivative 146,052 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0002021238-25-000006 · form4-10282025_041012.xml · derivative · entry 2

Kreitzer Anatol · CIK 0002021238 · Chief Discovery Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,052

Underlying: Voting Common Stock · 146,052 shares

Expires 2035-10-26

F3 · derivative.exercise_date: 1/4th of the total shares underlying the option shall vest on October 1, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.

Read SEC document
October 27, 2025 Filed Oct 28, 2025 20:15 UTC
Kreitzer AnatolChief Discovery Officer
GrantVoting Common Stock 35,953 $0.00 $0.00
Disclosure

SEC source: 0002021238-25-000006 · form4-10282025_041012.xml · nonDerivative · entry 1

Kreitzer Anatol · CIK 0002021238 · Chief Discovery Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,953

F1 · shares: Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on October 1, 2026, and 1/16th of the RSUs shall vest on each subsequent January 1, April 1, July 1 and October 1 thereafter, subject to the Reporting Person's continued service through each vesting date.

F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.

Read SEC document
October 27, 2025 Filed Oct 28, 2025 20:15 UTC
Setia VishwasChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 176,031 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0002021256-25-000006 · form4-10282025_041009.xml · derivative · entry 2

Setia Vishwas · CIK 0002021256 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 176,031

Underlying: Voting Common Stock · 176,031 shares

Expires 2035-10-26

F3 · derivative.exercise_date: 1/4th of the total shares underlying the option shall vest on October 1, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.

Read SEC document
October 27, 2025 Filed Oct 28, 2025 20:15 UTC
Setia VishwasChief Financial Officer
GrantVoting Common Stock 43,367 $0.00 $0.00
Disclosure

SEC source: 0002021256-25-000006 · form4-10282025_041009.xml · nonDerivative · entry 1

Setia Vishwas · CIK 0002021256 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,367

F1 · shares: Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on October 1, 2026, and 1/16th of the RSUs shall vest on each subsequent January 1, April 1, July 1 and October 1 thereafter, subject to the Reporting Person's continued service through each vesting date.

F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.

Read SEC document
October 27, 2025 Filed Oct 28, 2025 20:15 UTC
Foff Erin PennockChief Medical Officer
GrantEmployee Stock Option (right to buy) · Derivative 196,035 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0002021233-25-000007 · form4-10282025_041007.xml · derivative · entry 2

Foff Erin Pennock · CIK 0002021233 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 196,035

Underlying: Voting Common Stock · 196,035 shares

Expires 2035-10-26

F3 · derivative.exercise_date: 1/4th of the total shares underlying the option shall vest on October 1, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.

Read SEC document
October 27, 2025 Filed Oct 28, 2025 20:15 UTC
Foff Erin PennockChief Medical Officer
GrantVoting Common Stock 48,275 $0.00 $0.00
Disclosure

SEC source: 0002021233-25-000007 · form4-10282025_041007.xml · nonDerivative · entry 1

Foff Erin Pennock · CIK 0002021233 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,275

F1 · shares: Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on October 1, 2026, and 1/16th of the RSUs shall vest on each subsequent January 1, April 1, July 1 and October 1 thereafter, subject to the Reporting Person's continued service through each vesting date.

F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.

Read SEC document
October 27, 2025 Filed Oct 28, 2025 20:15 UTC
Kroeger Christopher A.Director · Chief Executive Officer
GrantEmployee Stock Option (right to buy) · Derivative 916,164 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0001658918-25-000008 · form4-10282025_041001.xml · derivative · entry 4

Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 916,164

Underlying: Voting Common Stock · 916,164 shares

Expires 2035-10-26

F5 · derivative.exercise_date: 1/4th of the total shares underlying the option shall vest on October 1, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.

Read SEC document
October 27, 2025 Filed Oct 28, 2025 20:15 UTC
Kroeger Christopher A.Director · Chief Executive Officer
GrantVoting Common Stock 225,693 $0.00 $0.00
Disclosure

SEC source: 0001658918-25-000008 · form4-10282025_041001.xml · nonDerivative · entry 1

Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,693

F1 · shares: Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on October 1, 2026, and 1/16th of the RSUs shall vest on each subsequent January 1, April 1, July 1 and October 1 thereafter, subject to the Reporting Person's continued service through each vesting date.

F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.

Read SEC document
October 27, 2025 Filed Oct 28, 2025 20:15 UTC
GILLIS JONATHANCAAO and PAO
GrantEmployee Stock Option (right to buy) · Derivative 124,022 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0001709954-25-000007 · form4-10282025_041014.xml · derivative · entry 2

GILLIS JONATHAN · CIK 0001709954 · CAAO and PAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,022

Underlying: Voting Common Stock · 124,022 shares

Expires 2035-10-26

F3 · derivative.exercise_date: 1/4th of the total shares underlying the option shall vest on October 1, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.

Read SEC document
October 27, 2025 Filed Oct 28, 2025 20:15 UTC
GILLIS JONATHANCAAO and PAO
GrantVoting Common Stock 30,565 $0.00 $0.00
Disclosure

SEC source: 0001709954-25-000007 · form4-10282025_041014.xml · nonDerivative · entry 1

GILLIS JONATHAN · CIK 0001709954 · CAAO and PAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,565

F1 · shares: Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on October 1, 2026, and 1/16th of the RSUs shall vest on each subsequent January 1, April 1, July 1 and October 1 thereafter, subject to the Reporting Person's continued service through each vesting date.

F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.

Read SEC document
October 27, 2025 Filed Oct 28, 2025 20:15 UTC
Lillie James WoodruffChief Scientific Officer
GrantEmployee Stock Option (right to buy) · Derivative 132,023 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0001728746-25-000007 · form4-10282025_041010.xml · derivative · entry 2

Lillie James Woodruff · CIK 0001728746 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,023

Underlying: Voting Common Stock · 132,023 shares

Expires 2035-10-26

F3 · derivative.exercise_date: 1/4th of the total shares underlying the option shall vest on October 1, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.

Read SEC document
October 27, 2025 Filed Oct 28, 2025 20:15 UTC
Lillie James WoodruffChief Scientific Officer
GrantVoting Common Stock 32,539 $0.00 $0.00
Disclosure

SEC source: 0001728746-25-000007 · form4-10282025_041010.xml · nonDerivative · entry 1

Lillie James Woodruff · CIK 0001728746 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,539

F1 · shares: Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on October 1, 2026, and 1/16th of the RSUs shall vest on each subsequent January 1, April 1, July 1 and October 1 thereafter, subject to the Reporting Person's continued service through each vesting date.

F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.

Read SEC document
October 27, 2025 Filed Oct 28, 2025 20:15 UTC GrantEmployee Stock Option (right to buy) · Derivative 25,604 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0001826519-25-000008 · form4-10282025_041018.xml · derivative · entry 2

Walker Maria C · CIK 0001826519 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,604

Underlying: Voting Common Stock · 25,604 shares

Expires 2035-10-26

F3 · derivative.exercise_date: 1/4th of the total shares underlying the option shall vest on October 1, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.

Read SEC document
October 27, 2025 Filed Oct 28, 2025 20:15 UTC GrantVoting Common Stock 6,294 $0.00 $0.00
Disclosure

SEC source: 0001826519-25-000008 · form4-10282025_041018.xml · nonDerivative · entry 1

Walker Maria C · CIK 0001826519 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,294

F1 · shares: Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on October 1, 2026, and 1/16th of the RSUs shall vest on each subsequent January 1, April 1, July 1 and October 1 thereafter, subject to the Reporting Person's continued service through each vesting date.

F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.

Read SEC document
October 27, 2025 Filed Oct 28, 2025 20:15 UTC
Hanson KristopherGeneral Counsel
GrantEmployee Stock Option (right to buy) · Derivative 110,046 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0001789970-25-000008 · form4-10282025_041016.xml · derivative · entry 2

Hanson Kristopher · CIK 0001789970 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,046

Underlying: Voting Common Stock · 110,046 shares

Expires 2035-10-26

F3 · derivative.exercise_date: 1/4th of the total shares underlying the option shall vest on October 1, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.

Read SEC document
October 27, 2025 Filed Oct 28, 2025 20:15 UTC
Hanson KristopherGeneral Counsel
GrantVoting Common Stock 27,098 $0.00 $0.00
Disclosure

SEC source: 0001789970-25-000008 · form4-10282025_041016.xml · nonDerivative · entry 1

Hanson Kristopher · CIK 0001789970 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,098

F1 · shares: Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on October 1, 2026, and 1/16th of the RSUs shall vest on each subsequent January 1, April 1, July 1 and October 1 thereafter, subject to the Reporting Person's continued service through each vesting date.

F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.